Project: Long-term imaging of organ-on-chip cultures: a proof-of-concept for metastatic melanoma-on-chip
| Acronym | IMAGINe (Reference Number: 11275) |
| Duration | 01/03/2018 - 28/02/2021 |
| Project Topic | IMAGINe will develop a device for long-term imaging of organ-on-chip (OoC) applications. This enabling technology controls the environment (e.g. temperature, fluid flow) of OoC cultures to keep these viable during imaging. The IMAGINe device uniquely enables the long-term monitoring of cellular processes in the OoC. This will be validated using a human skin-on-chip and a metastatic melanoma-on-chip model, in combination with novel cell-based therapeutics to inhibit metastasis. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 7 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Cherry Biotech SAS | Coordinator | France |
| 2 | IPD Therapeutics BV (traded as Glycostem Therapeutics) | Partner | Netherlands |
| 3 | Stichting VUmc | Partner | Netherlands |